| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/04/2008 | WO2008104486A1 Diagnostic and radiotherapeutic contrast agents and process for their preparation |
| 09/04/2008 | WO2008104271A2 Imaging probes |
| 09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | WO2008085064A3 Hydroxypyridinone chelating agents, their metal complexes and their use as mri contrast agents |
| 09/04/2008 | WO2008078190A3 Compounds for fluorescence imaging |
| 09/04/2008 | WO2008073634A3 Compositions and methods for detecting and treating endothelial dysfunction |
| 09/04/2008 | WO2008008402A3 Photo-acoustic detection device and method |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213189 Multifunctional metal-graphite nanocrystals |
| 09/04/2008 | US20080213187 Dendritic metal complexes of nitrogen-containing cascade with complex-forming ligands, >4 ions of preferably gadolinium, a Human Serum Albumen binding unit, a linker, and amines, acids and amides; contrast media for coronary angiography and NMR; high magnetic strength; tumors; ischemia; tolerance |
| 09/04/2008 | US20080213186 composition of Tris(8-carboxy-2,2,6,6-(tetra(methoxyethyl)benzo-[1,2-4,5']bis-(1,3)dithiole-4-yl)methyl sodium salt and hyperpolarised 13-pyruvate and pyruvic acid; radioactive C13 isotop; imaging agent for MR imaging; early stage detection of tumor |
| 09/04/2008 | US20080213185 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| 09/04/2008 | US20080213184 A method of reducing or preventing a drug-related effect or behavior by inhibiting an N-type calcium channel and is directed toward drugs of abuse, such as, , ethanol, cannabinoids, and opioids; screening conotoxin modulators to effect sedative, hypnotic, ataxia and drug reward and consumption |
| 09/04/2008 | US20080213183 Free or Liposomal Gemcitabine Alone or in Combination with Free or Liposomal Idarubicin |
| 09/04/2008 | US20080213181 Preparation of Paramagnetic Nanoparticles Conjugated to Leukotriene B4 (LTB4) Receptor Antagonists, and Their Use as MRI Contrast Agents for the Detection of Infection and Inflammation |
| 09/04/2008 | US20080213180 CA IX-Specific Inhibitors |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | US20080213177 Nanoparticles Comprising Rna Ligands |
| 09/04/2008 | US20080213176 Labelled peptide; an amino acid sequence of at least 7 amino acids, comprising a mid-part having a lysine residue, and terminal parts comprising consecutive glycine residues |
| 09/04/2008 | US20080212634 Optical Irradiation Device for the Polarization of Alkali Atoms and a Device for the Hyperpolarization of Noble Gases |
| 09/04/2008 | DE102007010860A1 Particle from a polymer material, useful e.g. in the medicinal diagnostic kit, comprises monodisperse in the material embedded fluorophore with absorption and fluorescence maxima in the ultraviolet/visible/near infra red-spectral area |
| 09/04/2008 | CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2678717A1 Imaging probes |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964846A1 Process for the preparation of contrast agents |
| 09/03/2008 | EP1963256A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 09/03/2008 | EP1962912A2 Method to produce hyperpolarised carboxylates of organic amines |
| 09/03/2008 | EP1962911A2 Novel imaging agents for fibrosis |
| 09/03/2008 | EP1962584A2 Novel gene disruptions, compositions and methods relating thereto |
| 09/03/2008 | EP1292613B1 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level |
| 09/03/2008 | EP0930844B1 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 09/03/2008 | CN101257928A Optical imaging contrast agents |
| 09/03/2008 | CN100415897C Microorganisms and cells for diagnosis and therapy of tumors |
| 09/02/2008 | US7419780 invention relates to the evolution of enzymes in vivo, and drug screening in vivo through the use of chemical inducers of protein dimerization |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2356942C Preparation of iodixanol |
| 09/02/2008 | CA2220706C Insoluble gas-filled microspheres containing a hydrophobic barrier |
| 09/02/2008 | CA2169696C Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them |
| 08/28/2008 | WO2008102065A1 Fluorescent emulsions for optical imaging |
| 08/28/2008 | WO2008021981A3 Local treatment of epidermal and dermal hyperproliferative lesions |
| 08/28/2008 | WO2008010980A3 Tat-049 and methods of assessing and treating cancer |
| 08/28/2008 | WO2007143715A3 Oxygen therapy with ultrasound |
| 08/28/2008 | US20080208167 Methods and compositions to treat myocardial conditions |
| 08/28/2008 | US20080208038 Method and Device For Representing the Microstructure of the Lungs |
| 08/28/2008 | US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080206152 In Vivo Expression Profiling |
| 08/28/2008 | US20080206151 Magnetic resonance imaging (MRI) contrast agent; synthesis by reacting acid-functional group with phosphoethanolamine and then with a peptide; amine containing phospholipids with functional groups in the liposome membrane that are useful as sites for binding |
| 08/28/2008 | US20080206150 Nanoparticles for Imaging Atherosclerotic Plaque |
| 08/28/2008 | US20080206149 Use in ophthalmic surgery, such as cataract surgery and/or vitrectomy; dyes selected from fluorescent dye, Lightgreen SF, Copper-phtalocyanine-tetrasulfonic acid tetrasodium salt (E68), Bromophenol blue and Chicago blue |
| 08/28/2008 | US20080206147 Radiopharmaceuticals, for use in Positron Emission Tomography (PET) |
| 08/28/2008 | US20080206146 Capable of crossing the blood brain barrier and having differential affinity for a tissue in the brain, such as diseased tissue; diagnosis; drug screening with animal model |
| 08/28/2008 | US20080206145 Gastro-Retentive Diagnostic Assemblies |
| 08/28/2008 | US20080206144 Identification of a truncation polymorphism of the mdr1 gene that is linked to ivermectin sensitivity in subjects such as collie dogs; use in bioassay testing to see which drugs certain canines will have adverse reactions to; pharmacogenetics |
| 08/28/2008 | US20080206143 Blockade of Elr+Cxc Chemokines as a Treatment For Inflammatory and Autoimmune Disease |
| 08/28/2008 | US20080206141 Optical Imaging Contrast Agents |
| 08/28/2008 | US20080206140 Antibodies specific to malignant cancer specific proliferating cell nuclear antigen (csPCNA) and not to the non-malignant proliferating cell nuclear antigen (nmPCNA) isoform; cancer diagnosis, prognosis, tumor detection and therapy; immunoassay kit |
| 08/28/2008 | US20080206139 Nanovesicles specifically targeted to abnormal cells; tissue-targeted therapy; central nervous system disorders such as astrocytoma; tumor-targeting therapy |
| 08/28/2008 | US20080206131 Compositions and Method for Multimodal Imaging |
| 08/28/2008 | US20080206130 In vivo panning for ligands to radiation-induced molecules |
| 08/27/2008 | EP1960393A1 Multimeric magentic resonance contrast agents |
| 08/27/2008 | EP1960003A2 Targeted nanoparticles for magnetic resonance imaging |
| 08/27/2008 | EP1960002A1 Aqueous dispersions of superparamagnetic single domain particles production and use thereof for diagnosis and therapy |
| 08/27/2008 | EP1960001A2 System and method for monitoring in vivo drug release using overhauser-enhanced nmr |
| 08/27/2008 | EP1960000A2 Method and apparatus utilizing animals for detecting target substances |
| 08/27/2008 | EP1748796A4 Multilayered nanomedicine delivery system and method |
| 08/27/2008 | EP1015039B1 Oxygen delivery agents and uses for the same |
| 08/27/2008 | CN101252954A Hydrazide conjugates as imaging agents |
| 08/27/2008 | CN101251527A Method for estimating Chinese medicine active ingredient intravenous injection patent medicine property |
| 08/27/2008 | CN101249269A Integrin targeted imaging agents |
| 08/27/2008 | CN101249268A Disinfection sterilizing type medical supersonic couplant and method of preparing the same |
| 08/27/2008 | CN101249020A Method and device for monitoring recording products use information |
| 08/26/2008 | US7418119 Display for computer-aided evaluation of medical images and for establishing clinical recommendation therefrom |
| 08/26/2008 | CA2327514C Method and kit for obtaining fluids and cellular material from breast ducts |
| 08/21/2008 | WO2008101154A2 Immunotherapy for immune suppressed patients |
| 08/21/2008 | WO2008101019A2 Molecular specific photoacoustic imaging |
| 08/21/2008 | WO2008099331A1 Arrangement for magnetic particle imaging, method for influencing and/or detecting magnetic particles and magnetic particle |
| 08/21/2008 | WO2008098958A1 C-terminal attachment of two chemical groups to peptides |
| 08/21/2008 | WO2008075192A3 Targeting and therapeutic compounds and gas-filled microvesicles comprising said com ounds |
| 08/21/2008 | WO2008054824A9 Methods for differential detection of hypoxic tissue in a mammalian subject |
| 08/21/2008 | WO2008031038A3 Pre- and intra-operative localization of penile sentinel nodes |
| 08/21/2008 | WO2007069040A3 Targeted nanoparticles for magnetic resonance imaging |
| 08/21/2008 | WO2007066247A3 System and method for monitoring in vivo drug release using overhauser-enhanced nmr |
| 08/21/2008 | US20080200373 Multi-Component Biological Transport Systems |
| 08/21/2008 | US20080199530 Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| 08/21/2008 | US20080199529 Nanoparticle delivery vehicle |
| 08/21/2008 | US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines |
| 08/21/2008 | US20080199404 Contrast Agents |
| 08/21/2008 | US20080199403 Administering meglumine diatrizoate, sodium diatrizoate, simethicone, famotidine and aspartame for clinical evaluations of appendicitis; organ-specific positive contrast effect; appendix visualization using computerized axial tomography; side effect reduction; diagnostic imaging |
| 08/21/2008 | US20080199402 Contrast Agents |
| 08/21/2008 | US20080199401 Hyperpolarized xenon gas is fed into blood plasma via a semi-permeable membrane that is permeable to gas; bubble-free dissolving; contrast medium for magnetic resonance analysis; hollow fiber membranes |
| 08/21/2008 | US20080199400 Otologic nanotechnology |
| 08/21/2008 | US20080199399 Interfacing Nanostructures to Biological Cells |
| 08/21/2008 | US20080199398 Polypeptide conjugate comprising helices of ApoA-1 apolipoproteins and peptide linking groups; antiinflammatory domain and/or domain that effects lecithin-cholesterol acyltransferase (LCAT); dyslipidemic disorders, stroke and myocardial infarction; cardiovascular disorders; detecting plaque |
| 08/21/2008 | US20080199397 Use of a Tetrapeptide Acsdkp Analogue Resistant to the Angiotensin i Conversion Enzyme, for Measuring Glomerular Filtration Rate in a Human or an Animal and Kit Containing Same |
| 08/21/2008 | CA2715529A1 Immunotherapy for immune suppressed patients |
| 08/21/2008 | CA2657649A1 Methods and compositions for targeting gc1qr/p32 |
| 08/20/2008 | EP1958646A1 Dual carrier immunogenic construct |
| 08/20/2008 | EP1957114A2 Novel imaging agents for fibrosis |